Filament Health Corp
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provide… Read more
Filament Health Corp (FLHLF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.257x
Based on the latest financial reports, Filament Health Corp (FLHLF) has a cash flow conversion efficiency ratio of -0.257x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-448.43K) by net assets ($1.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Filament Health Corp - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Filament Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Filament Health Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Filament Health Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kia Lim Bhd
KLSE:6211
|
0.014x |
|
ADVANCED ENERGY IND
BE:AVX
|
0.029x |
|
Wi2Wi Corporation
V:YTY
|
-0.128x |
|
WeCapital Holdings, Inc.
PINK:WCHD
|
N/A |
|
China Natural Resources Inc
NASDAQ:CHNR
|
-0.048x |
|
Fund.com Inc
PINK:FNDM
|
0.049x |
|
Greenwave Technology Solutions Inc. Common Stock
NASDAQ:GWAV
|
-0.100x |
|
PVW Resources Ltd
AU:PVW
|
1.812x |
Annual Cash Flow Conversion Efficiency for Filament Health Corp (2020–2024)
The table below shows the annual cash flow conversion efficiency of Filament Health Corp from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.75 Million | $-2.29 Million | -1.310x | +22.06% |
| 2023-12-31 | $2.49 Million | $-4.19 Million | -1.681x | -38.80% |
| 2022-12-31 | $3.19 Million | $-3.87 Million | -1.211x | -270.68% |
| 2021-12-31 | $16.55 Million | $-5.41 Million | -0.327x | -247.81% |
| 2020-12-31 | $813.64K | $-76.42K | -0.094x | -- |